Objective Symptoms and clinical course during inflammatory bowel disease (IBD) vary among individuals. Personalised care is therefore essential to effective management, delivered by a strong patient-centred multidisciplinary team, working within a well-designed service. This study aimed to fully rewrite the UK Standards for the healthcare of adults and children with IBD, and to develop an IBD Service Benchmarking Tool to support current and future personalised care models. Design Led by IBD UK, a national multidisciplinary alliance of patients and nominated representatives from all major stakeholders in IBD care, Standards requirements were defined by survey data collated from 689 patients and 151 healthcare professionals. Standards were drafted and refined over three rounds of modified electronic-Delphi. results Consensus was achieved for 59 Standards covering seven clinical domains; (1) design and delivery of the multidisciplinary IBD service;
PROFESSIONAL MATTERS
developed by patient and professional associations and were published in 2009 in response to a UK-wide audit highlighting significant variation in care. 7 The IBD Standards defined what was required in terms of staff, support services, organisation, patient education and audit to provide integrated, high-quality IBD services. The 2013 updated IBD Standards 8 underpinned the 2015 National Institute for Health and Care Excellence (NICE) quality standard on IBD (QS81) 9 and were an integral component of the IBD Quality Improvement Programme in the UK 10 supported by the Royal College of Physicians until 2015.
The fourth and final round of the UK IBD Audit in 2014 has demonstrated improvements in several areas of service provision, including increased numbers of IBD nurse specialists and dietitians and reduced mortality. 11 12 However, it has also shown continuing variation in the quality and responsiveness of healthcare for people with IBD in the UK. Considerable issues have been highlighted in a number of areas, in particular, speed of access to specialist assessment at referral and relapse; appropriate provision for IBD nurse specialists, dietetic access and psychological support; patient education opportunities and involvement of patients in service planning. Previous rounds of audit have also shown a need for improved communication between primary care and secondary care. 13 Recent work in the UK by Crohn's & Colitis UK has shown that factors such as loneliness, degree of control and involvement in care are significantly associated with active disease, a reduction in quality of life and low life satisfaction. 14 The considerable psychosocial impact of IBD on education, careers, social and intimate wellbeing is well-documented in quality of life studies. 15 16 Furthermore, patient surveys have drawn attention to concerns around delays in diagnosis, timeliness of review and treatment, access to appropriate inpatient facilities, coordination and continuity of care. 17 The surveys also highlight needs relating to patients' understanding about their condition, available treatment options and involvement in shared decision-making.
The individual impact of IBD and experience of IBD services, together with an increasing focus on personalised care in the NHS 6 across the UK, underlines the need for quality improvement methodologies in IBD. Future service design and development must be patient-centred and must include mechanisms to capture service outcomes that enable patients to monitor impact and shape solutions in the delivery of IBD services. The National Cancer Patient Experience Survey 2017 demonstrated significant improvement on 21/52 questions compared with the previous year's results, 18 highlighting the potential benefit of this type of approach if used to shape future UK IBD care.
Therefore, a complete revision of the UK IBD Standards was considered essential. This is particularly important due to the significant changes in IBD management since 2013, such as the complex range of new medical therapy options, the growing use of minimally invasive surgical techniques in the UK; the increased use, the general acceptance and use of new web-based communication technology; and recognition of the central importance of involving the patient in decision-making.
MethoDs
The IBD Standards 2019 methodology was designed to align with the 2019 British Society of Gastroenterology (BSG) IBD guidelines 19 and the 2018 Association of Coloproctology of Great Britain and Ireland (ACPGBI) IBD surgical guidelines. 20 In addition, the process considered other relevant professional and NICE guidelines.
IbD uK and national stakeholders
The Standards development process was led from its inception by IBD UK, a national multidisciplinary alliance of nominated representatives from patient and professional organisations, with integrated patient involvement on the Standards Development Group and at all stages of the development process. Representation from all devolved nations ensured standards were applicable throughout the UK. The following organisations/stakeholders were represented by IBD UK (author affiliations or membership are denoted by initials): 
Suggestions for inclusion in 2019 IBD Standards
► Guidance on appropriate and accessible information, communication and support for patients at all points to improve understanding and selfmanagement, enhance a sense of personal control/empowerment and alleviate the isolation many feel. ► Mental health referral pathways/training to give emotional support and regular mental health assessments from diagnosis. ► An emphasis on holistic treatment and care, including wider symptoms such as pain and fatigue, joint and skin conditions. ► Focus on what constitutes effective shared and coordinated care, including between different specialists, primary and secondary care and accident and emergency and the IBD team. ► Strengthen sections outlining opportunities for patient and carer involvement in improving IBD services. ► Clear recommendations on time frames for diagnosis, access to advice, investigations, medication and surgery. ► A personalised care plan for every person with IBD that they jointly develop and have access to, which includes mental health, dietetic support, lifestyle advice, medication reviews, regular monitoring and alternatives to medicines. ► Greater emphasis on preventing flares, including education on identifying signs and development of individual plans around prevention. ► Guidance on what shared decision-making should look like, particularly in relation to medications.
Suggestions for 2019 IBD Standards
► Strengthened focus on the role of primary care to enable more seamless care. ► Increased detail relating to surgery. ► Greater clarity around delivery of biologics services. ► More specific requirements for the level of dietetic service that should be provided. ► Improved emphasis on paediatric and adolescent IBD. ► Increased focus on involvement of service users. ► Expanded methods to help patients stay well and to prevent flares as far as possible. ► More accessible, user-friendly and patient journey orientated. ► Resources to support service development, including business case templates and patient stories, benchmarking toolkit and links to clinical guidance. ► Importance of outcomes (including quality of life) and quality metrics, linkages with IBD Registry and RCP QI programme. design and delivery should be updated or reinforced in light of evolving evidence-based clinical practice, patient perception and expert opinion.
IbD standards consensus development and e-Delphi
Informed by the above patient and healthcare professional surveys and critical review of prior Standards iterations, the Standards Development Group then drafted statements. A reference group of 17 patients/ carers from throughout the UK, who had previous experience of activity related to IBD service improvement, gave feedback on the Standards working document. The IBD Standards were then refined across three rounds of anonymised modified e-Delphi voting, developing recommendations for optimal service design and delivery and in relation to quality improvement or key performance measures; 28 voters assessed each statement on a 5-point scale (strongly agree (SA), agree (A), neither agree nor disagree (N), disagree (D) or strongly disagree (SD)). After each round of voting, the Standards were assessed and, if necessary, redrafted based on voter feedback. Agreement was defined as a score of 'agree' or 'strongly agree'. Consensus agreement was defined as >80% agreement from the group. e-Delphi voters represented patients and all professional groups, including specialist nurses, gastroenterologists, colorectal surgeons, paediatricians, general practitioners (GPs), radiologists, pathologists, dietitians and pharmacists. Voters were geographically representative of the UK.
Development of the IbD benchmarking tool
Led by IBD UK, a Benchmarking Development Group identified the core components of service delivery, based on established good practice and/or multidisciplinary expert consensus at grading levels A-D to cover the range of IBD Standards statements. The service self-assessment tool was tested in a range of services and refined based on feedback. Development of the patient survey was led by Crohn's & Colitis UK for IBD UK, with questions mapped to the IBD Standards statements and graded A-D in line with the service self-assessment tool. Initial questions were refined following feedback from a reference group of patients and parents/carers and were further cognitively tested through a focus group and telephone interviews. examples of the use of previous versions of the IBD Standards and suggestions for inclusion in this iteration of the Standards were cited by respondents. A thematic summary of these responses is presented in table 1.
An online survey carried out by IBD UK of 689 patients (45% Crohn's disease, 40% ulcerative colitis, 3.3% IBDU, 0.7% microscopic colitis and 2% "other") was assessed to determine patient preference for content of the IBD Standards and what would make the greatest impact on patient care. Thematic conclusions from this survey are summarised in table 1.
IbD service standards
The 2019 IBD Standards were created to reflect the central position and importance of the patient in service design and delivery. In particular, a strengthened focus on surgery, primary care, paediatrics and patient empowerment was identified relative to previous iterations of the Standards. Accompanying tools and resources and a benchmarking process to support implementation were also advocated. The Standards development process therefore set out to follow the patient journey across seven sections from referral, through diagnosis, surgical and medical treatment, to long-term management of IBD (figure 1). The consensus IBD Standards following three rounds of modified e-Delphi are presented in boxes 1-7 according to each of the seven sections.
IbD service benchmarking tool
In the online survey of 151 healthcare professionals, over 90% of respondents agreed that a benchmarking tool would be useful to support implementation of the IBD Standards. A new web-based tool has been developed to address this need (figure 2). The tool benchmarks against the revised IBD Standards and builds on the approach undertaken by the IBD Quality Improvement Project (IBD QIP) tool 10 and the endoscopy Global Rating Scale. 21 The unique strength of this tool is that both patient experience and service performance can be measured and benchmarked. This is achieved by a web-based self-assessment completed by the healthcare team and a different survey completed by patients.
Within the Benchmarking Tool, the IBD Standards core statements (boxes 1-7) are represented across four domains of access, coordinated care, patient empowerment and quality. Each domain is subdivided into diagnosis, treatment, ongoing care and IBD service, with corresponding questions on both the patient survey and service self-assessment tool. Based on a set of agreed descriptors, gradings can be generated based on the results of the patient survey and through the service self-assessment process, ranging from 'excellent, proactive' to 'minimal, inadequate' care. Services will thereby be able to identify areas that clearly require quality improvement and to make the case for additional resources where needed. The benchmarking tool will enable clinical teams to compare self-assessment of service performance with patient experience across all domains, as well as with the UK average, the UK devolved nation average and the previous year's results for the service. Additional resources will be available through the IBD UK website to support quality improvement (https:// ibduk. org/). A, agree; IBD, inflammatory bowel disease; N, neither agree nor disagree; SA, strongly agree.
DIscussIon
The development of these IBD Standards was essential as a benchmark against which IBD care can be measured. Compared with the second UK IBD Standards from 2013, the 2019 Standards differ substantially both in structure (reflecting the patient journey) and in content, as a result of substantial changes in service delivery in the last 6 years. The Standards reflect the increasing complexity of IBD management: the need for pre-treatment safety screening and therapeutic monitoring; the importance of shared decision-making between the IBD health professional team and the patient; the increasing involvement of Allied Healthcare Professionals, such as dietitians, psychologists and pharmacists, in the management of chronic disease patients; the need for partnership between hospitals, primary care and the patient in the delivery of care; and the growing use of technology to improve communication and patient education. A, agree; D, disagree; IBD, inflammatory bowel disease; SA, strongly agree; SD, strongly disagree.
The Standards complement the recently published BSG and ACPGBI IBD guidelines. 19 20 While these guidelines provide the evidence base and detail of current management, the Standards define a high-quality IBD service, including a number of objective measures of quality. This provides a cohesive and accessible framework for service development. The IBD Standards align with the 2015 NICE Quality Standard, 9 providing much greater detail to support effective delivery of this.
The strengths of these Standards include the process by which they were developed. A strong expert consensus was achieved through a rigorous approach with representation across all relevant professional disciplines and UK stakeholders in IBD care, in addition to consistent input from patients and their organisations. The role of the patient organisation Crohn's & Colitis UK in leading their development ensures that the primary focus is on the patient and their copyright. to their IBD should be admitted directly, or transferred within 24-48 hours, to a designated specialist ward area under the care of a consultant gastroenterologist and/or colorectal surgeon (consensus 97%: SA 61%, A 36%, D 3%). Statement 6.2: Where ensuite rooms are not available, inpatients with IBD should have a minimum of one easily accessible toilet per three beds on a ward (consensus 97%: SA 61%, A 36%, N 3%). Statement 6.3: Inpatients with IBD must have 24-hour rapid access to critical care services if needed (consensus 97%: SA 79%, 18%, N 3%). Statement 6.4: Children and adults admitted as inpatients with acute severe colitis should have daily review by appropriate specialists (consensus 96%: SA 75%, A 21%, N 4%). Statement 6.5: For patients with acute severe colitis, stool culture and Clostridium difficile assay should be performed on admission to exclude infectious causes of colitis (consensus 100%: SA 71%, A 29%). Statement 6.6: For patients admitted with acute severe colitis, limited flexible sigmoidoscopy, when indicated, should be performed without bowel preparation by an experienced endoscopist (consensus 100%: SA 64%, A 36%). Statement 6.7: All patients with acute severe colitis not settling on intravenous steroids should be assessed regularly by a consultant adult/paediatric colorectal surgeon and a decision made with the patient and adult/paediatric gastroenterologist on day three to escalate to rescue therapy or undertake a colectomy (Consensus 93%: SA 61%, A 32%, N 4%, D 3%). Statement 6.8: On admission, patients with IBD should have an assessment of nutritional status, mental health and pain management using validated tools, and should be referred to services and support as appropriate (consensus 100%: SA 50%, A 50%). Statement 6.9: All inptients with IBD should have access to an IBD nurse specialist (consensus 100%: SA 71%, A 29%). Statement 6.10: All inpatients with IBD should have their prescribed and over the counter medications reviewed on admission by a pharmacist who has access to an expert pharmacist in IBD for advice, with regular review of medications during their inpatient stay and at discharge (consensus 100%: SA 46%, A 54%). Statement 6.11: Clear written information about follow-up care and prescribed medications should be provided before discharge from the ward and communicated to the patient's IBD clinical team and GP within 48 hours of discharge (consensus 100%: SA 57%, A 43%).
A, agree; D, disagree; IBD, inflammatory bowel disease; N, neither agree nor disagree; SA, strongly agree. The Standards are laid out in an accessible form and cover many aspects of IBD service delivery that can be measured. Two tools were developed to assess the service: the benchmarking tool designed for professionals' IBD service self-assessment and the survey tool designed for patients. Assessing a service both from the provider's perspective and from that of the patients treated within that service is unique in IBD and may create an important tension for change in the absence of system-wide levers for service development.
There are limitations in the breadth of the evidence base used in formulating these Standards. For example, there are no data to validate the appropriate maximum time interval within which treatment can be started safely. However, the focus has been to define targets that are acceptable to patients and appropriate to the constraints of the NHS while being relevant also to other healthcare systems. The value of the IBD Standards is dependent on their implementation. The Standards define criteria that may not be achievable by every IBD service, but their purpose is to encourage service quality improvement. Fundamental to this is 
Figure 2
The IBD Service Benchmarking Tool. The 2019 IBD Standards form the basis for a web-based benchmarking tool with corresponding healthcare professional self-assessment and patient survey portals. Within this system, IBD services will be able to assess their own performance according to the Standards and see how they benchmark against other regional and national services. Healthcare professional self-assessment of their service can be presented alongside patient survey results for the same service across a range of domains. Quality improvement, personalised care and shared decisionmaking will be promoted through a range of online support tools, guidelines and case studies. IBD, inflammatory bowel disease.
Significance of this study
What is already known about this subject? ► Inflammatory bowel disease (IBD) is a chronic relapsing remitting condition that affects 500 000 people or more in the UK. PROFESSIONAL MATTERS be completed. Data will be collected through the IBD UK website, and the data controller will be Crohn's & Colitis UK. The intention is for both patient survey and IBD service reports to be publicly available from the IBD UK website. The data will be used to inform IBD services and enable them to drive quality improvement, encouraging providers and patients to work in partnership.
conclusIon
The third UK IBD Standards comprise 59 consensus statements across seven clinical areas that make up the journey of patients with IBD. They have been developed by the IBD UK group, with patient involvement at all stages, and they represent the items that are necessary for delivery of a high-quality IBD service. They are integrated with current UK IBD guidelines and endorsed by relevant professional bodies. They are supported by benchmarking tools that are appropriate for use by healthcare professionals and by patients. Using these tools, services can measure their own performance, obtain feedback from patients and compare their service with others, with the overall aim of driving up the quality of services supporting patients with IBD. 
